These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 33359271)

  • 21. Superiority of long-acting to short-acting loop diuretics in the treatment of congestive heart failure.
    Masuyama T; Tsujino T; Origasa H; Yamamoto K; Akasaka T; Hirano Y; Ohte N; Daimon T; Nakatani S; Ito H
    Circ J; 2012; 76(4):833-42. PubMed ID: 22451450
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of 30-Day All-Cause Readmission with Long-Term Outcomes in Hospitalized Older Medicare Beneficiaries with Heart Failure.
    Arundel C; Lam PH; Khosla R; Blackman MR; Fonarow GC; Morgan C; Zeng Q; Fletcher RD; Butler J; Wu WC; Deedwania P; Love TE; White M; Aronow WS; Anker SD; Allman RM; Ahmed A
    Am J Med; 2016 Nov; 129(11):1178-1184. PubMed ID: 27401949
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intensification of pharmacological decongestion but not the actual daily loop diuretic dose predicts worse chronic heart failure outcome: insights from TIME-CHF.
    Simonavičius J; Maeder MT; Eurlings CGMJ; Aizpurua AB; Čelutkienė J; Barysienė J; Toggweiler S; Kaufmann BA; Brunner-La Rocca HP
    Clin Res Cardiol; 2021 Aug; 110(8):1221-1233. PubMed ID: 33216179
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative effectiveness of loop diuretics on mortality in the treatment of patients with chronic heart failure - A multicenter propensity score matched analysis.
    Täger T; Fröhlich H; Grundtvig M; Seiz M; Schellberg D; Goode K; Kazmi S; Hole T; Katus HA; Atar D; Cleland JGF; Agewall S; Clark AL; Frankenstein L
    Int J Cardiol; 2019 Aug; 289():83-90. PubMed ID: 30827731
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Loop diuretic therapy in heart failure: the need for solid evidence on a fluid issue.
    Chiong JR; Cheung RJ
    Clin Cardiol; 2010 Jun; 33(6):345-52. PubMed ID: 20556804
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of serum uric acid change with mortality, renal function and diuretic dose administered in treatment of acute heart failure.
    Zhou HB; Xu TY; Liu SR; Bai YJ; Huang XF; Zhan Q; Zeng QC; Xu DL
    Nutr Metab Cardiovasc Dis; 2019 Apr; 29(4):351-359. PubMed ID: 30795993
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association between changes in loop diuretic dose and outcomes in acute heart failure.
    Seko Y; Kato T; Morimoto T; Yaku H; Inuzuka Y; Tamaki Y; Ozasa N; Shiba M; Yamamoto E; Yoshikawa Y; Yamashita Y; Kitai T; Taniguchi R; Iguchi M; Nagao K; Kawai T; Komasa A; Nishikawa R; Kawase Y; Morinaga T; Toyofuku M; Furukawa Y; Ando K; Kadota K; Sato Y; Kuwahara K; Kimura T;
    ESC Heart Fail; 2023 Jun; 10(3):1757-1770. PubMed ID: 36858382
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical value of pre-discharge bio-adrenomedullin as a marker of residual congestion and high risk of heart failure hospital readmission.
    Pandhi P; Ter Maaten JM; Emmens JE; Struck J; Bergmann A; Cleland JG; Givertz MM; Metra M; O'Connor CM; Teerlink JR; Ponikowski P; Cotter G; Davison B; van Veldhuisen DJ; Voors AA
    Eur J Heart Fail; 2020 Apr; 22(4):683-691. PubMed ID: 31797505
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of adding nitroglycerin to early diuretic therapy on the morbidity and mortality of patients with chronic kidney disease presenting with acute decompensated heart failure.
    Aziz EF; Kukin M; Javed F; Pratap B; Sabharwal MS; Tormey D; Frankenberger O; Herzog E
    Hosp Pract (1995); 2011 Feb; 39(1):126-32. PubMed ID: 21441767
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Higher doses of loop diuretics limit uptitration of angiotensin-converting enzyme inhibitors in patients with heart failure and reduced ejection fraction.
    Ter Maaten JM; Martens P; Damman K; Dickstein K; Ponikowski P; Lang CC; Ng LL; Anker SD; Samani NJ; Filippatos G; Cleland JG; Zannad F; Hillege HL; van Veldhuisen DJ; Metra M; Voors AA; Mullens W
    Clin Res Cardiol; 2020 Aug; 109(8):1048-1059. PubMed ID: 32002631
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of Loop Diuretic on Outcomes in Patients with Heart Failure and Reduced Ejection Fraction.
    Antonietta CM; Calvi E; Faggiano A; Maffeis C; Bosisio M; De Stefano M; Carugo S; Faggiano P
    Curr Heart Fail Rep; 2022 Feb; 19(1):15-25. PubMed ID: 35037162
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Changing views on the place of loop and thiazide diuretics in the treatment of chronic heart failure. Part II. Influence on outcomes and clinical application].
    Sidorenko BA; Preobrazhesnkiĭ DV; Bataraliev TA; Pershukov IV; Makhmutkhodzhaev SA
    Kardiologiia; 2005; 45(9):99-104. PubMed ID: 16234805
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of short-acting vs. long-acting loop diuretics after heart failure hospitalization.
    Imaeda S; Shiraishi Y; Kohsaka S; Niimi N; Goda A; Nagatomo Y; Takei M; Saji M; Nakano S; Kohno T; Fukuda K; Yoshikawa T
    ESC Heart Fail; 2022 Oct; 9(5):2967-2977. PubMed ID: 35730147
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of Torsemide vs Furosemide After Discharge on All-Cause Mortality in Patients Hospitalized With Heart Failure: The TRANSFORM-HF Randomized Clinical Trial.
    Mentz RJ; Anstrom KJ; Eisenstein EL; Sapp S; Greene SJ; Morgan S; Testani JM; Harrington AH; Sachdev V; Ketema F; Kim DY; Desvigne-Nickens P; Pitt B; Velazquez EJ;
    JAMA; 2023 Jan; 329(3):214-223. PubMed ID: 36648467
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum and Urine Albumin and Response to Loop Diuretics in Heart Failure.
    Charokopos A; Griffin M; Rao VS; Inker L; Sury K; Asher J; Turner J; Mahoney D; Cox ZL; Wilson FP; Testani JM
    Clin J Am Soc Nephrol; 2019 May; 14(5):712-718. PubMed ID: 31010938
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Loop diuretic strategies in patients with acute decompensated heart failure: a meta-analysis of randomized controlled trials.
    Wu MY; Chang NC; Su CL; Hsu YH; Chen TW; Lin YF; Wu CH; Tam KW
    J Crit Care; 2014 Feb; 29(1):2-9. PubMed ID: 24331943
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative Analysis of Long-Term Outcomes of Torasemide and Furosemide in Heart Failure Patients in Heart Failure Registries of the European Society of Cardiology.
    Ozierański K; Balsam P; Kapłon-Cieślicka A; Tymińska A; Kowalik R; Grabowski M; Peller M; Wancerz A; Marchel M; Crespo-Leiro MG; Maggioni AP; Drożdż J; Filipiak KJ; Opolski G
    Cardiovasc Drugs Ther; 2019 Feb; 33(1):77-86. PubMed ID: 30649675
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Loop Diuretic Use is Associated With Adverse Clinical Outcomes in Acute Myocardial Infarction Patients With Low Volume Status.
    Kawai T; Nakatani D; Watanabe T; Yamada T; Morita T; Sakata Y; Hikoso S; Mizuno H; Suna S; Kitamura T; Okada K; Dohi T; Sotomi Y; Sunaga A; Kida H; Oeun B; Sato T; Sato H; Hori M; Komuro I; Fukunami M; Sakata Y;
    Curr Probl Cardiol; 2022 Nov; 47(11):101326. PubMed ID: 35870545
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discharge Diuretic Dose and 30-Day Readmission Rate in Acute Decompensated Heart Failure.
    Woodruff AE; Kelley AM; Hempel CA; Loeffler WJ; Echtenkamp CA; Hassan AK
    Ann Pharmacother; 2016 Jun; 50(6):437-45. PubMed ID: 26956954
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acetazolamide to increase natriuresis in congestive heart failure at high risk for diuretic resistance.
    Verbrugge FH; Martens P; Ameloot K; Haemels V; Penders J; Dupont M; Tang WHW; Droogné W; Mullens W
    Eur J Heart Fail; 2019 Nov; 21(11):1415-1422. PubMed ID: 31074184
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.